Ingrezza - Beating Your Ass

Discussion in 'Teva Neuroscience' started by NBIX, Jul 29, 2019 at 8:40 PM.

Tags: Add Tags
  1. NBIX

    NBIX Guest

    The earnings call for Neurocrine Biosciences was not just a celebration for them and their investors, but yet more evidence of the beatdown Teva is getting in most markets across the country

    $7 stock - Old and tired big pharma dinosaur approach with actual dinosaurs in sales leadership incapable of high level thought, a temp agency posing as marketing, and a corporate structure that is closer to a reality tv show contract than a drug company turnaround

    $97 stock - Energetic progressive leaders that are really smart, who actually hire other really smart people and then allow them to think through business solutions
     

  2. anonymous

    anonymous Guest

     
  3. anonymous

    anonymous Guest

    Bro, do you even work out?
     
  4. anonymous

    anonymous Guest

    Are you sure you didn't mean to say Ingrezza is eating ass?
     
  5. anonymous

    anonymous Guest

    What is a tosylate, and why are the bad? Does anyone understand what EMEA 44714 2008 is talking about?
     
  6. anonymous

    anonymous Guest

    Do they cause severe parkinsonism reactions that put patients in the hospital like Ingrezza does?
     
  7. anonymous

    anonymous Guest

    Doesn’t matter, you guys will be bankrupt by the end of the year. None of us are concerned about a $7 a share penny stock company like Teva.
     
  8. anonymous

    anonymous Guest

    Same as losartan recall
     
  9. anonymous

    anonymous Guest

    Ass beating you say ?

    This is a job for the captain.
     
  10. anonymous

    anonymous Guest

    Be careful why you wish for , executive leadership love the reacharounds and gloryhole s
     
  11. anonymous

    anonymous Guest

    Everyone working at Teva is an ass bandit
     
  12. anonymous

    anonymous Guest

    Why is Teva HR such a bunch of useless asses?
     
  13. anonymous

    anonymous Guest

    Ever noticed Teva has more directors than actual workers - no wonder the company is such a disaster
     
  14. anonymous

    anonymous Guest

    How’s that Igrezza market share now ?
     
  15. anonymous

    anonymous Guest

    Dog
     
  16. anonymous

    anonymous Guest

    Teva are a circus , worst pharma company ever
     
  17. anonymous

    anonymous Guest

    Funny thing is every single one of you wish you could sell Ingrezza, market share or not you have a sub par product and know it
     
  18. anonymous

    anonymous Guest

    Ok, lets see how smart you are? Name just 1 reason why Ingrezza is better than Austedo and watch how many simple objections show up here as to why we are at least comparable or better. And don't take the easy way out with the "dosing thing", since you know what's already here with XR and what's about to come within the next 30 days or so.